| Title | Venue | Year | Impact | Source |
| 6251 | POS-850 EFFECT OF COVID-19 ON POST RENAL TRANSPLANTATION PATIENTS | Kidney Int Rep | 2022 | | CORD-19 |
| 6252 | POS-840 Acute kidney injury in critically ill COVID- 19 infected patients requiring renal replacement therapy | Kidney Int Rep | 2022 | | CORD-19 |
| 6253 | POS-944 CLINICAL PRESENTATION AND OUTCOMES OF COVID-19 IN MAINTENANCE HEMODIALYSIS PATIENTS IN PAKISTAN: A SINGLE-CENTER STUDY | Kidney Int Rep | 2022 | | CORD-19 |
| 6254 | POS-994 ANTIBODY RESPONSE TO COVID-19 VACCINATION IN CHRONIC KIDNEY DISEASE PATIENTS ON MAINTENANCE HEMODIALYSIS | Kidney Int Rep | 2022 | | CORD-19 |
| 6255 | POS-960 ASSOCIATION OF PARATHYROID HORMONE LEVEL WITH SEVERITY OF CORONAVIRUS induced PNEUMONIA IN HEMODIALYSIS PATIENTS | Kidney Int Rep | 2022 | | CORD-19 |
| 6256 | POS-945 THE ROLE OF HEMOPERFUSION AS A COUNTERMEASURE FOR CYTOKINE STORM IN COVID-19 PATIENTS ADMITTED IN A PUBLIC TERTIARY HOSPITAL IN DAVAO CITY | Kidney Int Rep | 2022 | | CORD-19 |
| 6257 | POS-943 ADHERENCE TO THE TREATMENT OF TRANSPLANTED PATIENTS FROM A PHI IN BARRANQUILLA IN TIMES OF THE COVID-19 | Kidney Int Rep | 2022 | | CORD-19 |
| 6258 | POS-977 RISK OF COVID-19 INFECTION POST VACCINATION PROGRAMME IN PATIENTS WITH END STAGE KIDNEY DISEASE IN PENANG STATE | Kidney Int Rep | 2022 | | CORD-19 |
| 6259 | POS-970 PREVALENCE OF SARS-CoV-2 INFECTION IN HAEMODIALYSIS PATIENTS- A RETROSPECTIVE STUDY | Kidney Int Rep | 2022 | | CORD-19 |
| 6260 | POS-948 OUTCOME OF COVID-19 INFECTION AMONG IN-CENTER HEMODIALYSIS AND HOME-BASED PERITONEAL DIALYSIS PATIENTS HOSPITALISED IN NEGERI SEMBILAN: A MULTICENTER EXPERIENCE | Kidney Int Rep | 2022 | | CORD-19 |
| 6261 | POS-958 CORONAVIRUS-DISEASE 2019 IN CHRONIC PERITONEAL DIALYSIS POPULATION: CHARACTERISTICS AND OUTCOME | Kidney Int Rep | 2022 | | CORD-19 |
| 6262 | POS-950 COVID-19 IN END STAGE KIDNEY DISEASE WITH RENAL REPLACEMENT THERAPIES: OUR EXPERIENCE IN PENANG | Kidney Int Rep | 2022 | | CORD-19 |
| 6263 | POS-984 Impact of covid-19 pandemic on Malaysian nephrology fellow training and well-being | Kidney Int Rep | 2022 | | CORD-19 |
| 6264 | POS-849 CHARACTERISTICS AND OUTCOMES OF HOSPITALIZED COVID-19 PATIENTS WITH ACUTE KIDNEY INJURY | Kidney Int Rep | 2022 | | CORD-19 |
| 6265 | POS-277 AN ONLINE SURVEY ON THE AWARENESS OF NON-COMMUNICABLE DISEASES IN INDIA Introduction: Awareness is the corner stone for self-care. Prevalence of Non-Communicable Diseases (NCDs) like Diabetes mellitus (DM) and Hypertension are increasing both in developed and developing world. They are associated with end-organ damage, poor quality of life and increased morbidity and mortality. Symptoms of NCDs or its complications appear late, delaying detection and loss of precious time for preventive interventions. It is important therefore for the general public to be aware of NCDs and their complications. The reach of social media is ever expanding being readily available on smart phones and can be put to good use to improve cognizance of NCDs among people. This study was done, with the intention to know the awareness of NCDs among the general public as compared to their knowledge of Corona Virus - COVID (SARS-COV2) infection, while in the midst of the pandemic, and Tuberculosis (TB), for both of which there is a government led education awareness program on traditional and social media in India. Methods: This was an online questionnaire survey in 6 Indian languages. The link for the questionnaire, was shared on the social media such as Twitter and Facebook and sent to known WhatsApp groups. They were requested to answer and forward it to their contacts. All the submissions were done between 21-01-2021 and 12-04-2021. Out of a total of 323, duplicates (156) were excluded and 167 responses were analyzed using excel sheet. Results: The average age of the respondents (n=167) was 35.5 years, 159 (95.2%) had at-least 12 years of school education;65 (38.9%) were males. There were 6.0%, 13.2% and 18.6% of respondents who had not heard of DM, hypertension and kidney diseases respectively;Of these respondents - 10.8%, 10.2% and 4.2% themselves had DM, hypertension and kidney diseases respectively (See Table 1). Among all the respondents, 20.4% and 17.4% could not recognize that high blood sugar was DM and high blood pressure was hypertension respectively. They were not aware that DM (59.9%) and hypertension (70.1%) could cause kidney disease. Among those who had DM, 44.4% were aware that kidney failure was a complication of DM: similarly, 23.53% of those who had hypertension, were aware that kidney failure was a complication of Hypertension. 77.78% of diabetics and 70.59% of hypertensives were aware that the medications should not be stopped even when there are no symptoms (See Table 1). In comparison to NCDs, information about TB and Corona Virus - COVID infection (SARS-COV2) was as follows. 124 (74.25%), were aware about TB;among them, 83.87% recognized blood in sputum as a symptom and 89.52% were aware of the availability of tablets for TB. 146 (87.43%) were aware about COVID, among them 87.1% recognized cough as a symptom and 89.52% were aware of the availability of treatment for COVID. At a time when vaccination for COVID was just being made available, 37.9% were not aware of the Vaccine. (See Table 2). [Formula presented] [Formula presented] Conclusions: Awareness about NCDs and their complications is poor. School curriculum should include spreading awareness. Even among patients with NCDs, understanding of the disease, tests to be done, symptoms, importance of compliance with medications and complications are lacking. There is an urgent need to appraise people about this. This study was limited by the small sample size, inadequate rural population representation and inherent bias of social media responses. No conflict of interest | Kidney Int Rep | 2022 | | CORD-19 |
| 6266 | POS-290 MORTALITY IN COVID-19 PATIENTS WITH CKD WITH AND WITHOUT KIDNEY REPLACEMENT THERAPY IN WESTERN MEXICO | Kidney Int Rep | 2022 | | CORD-19 |
| 6267 | POS-014 THE RELATIONSHIP BETWEEN IL-6, IL-10, TNF-alpha WITH AKI IN MODERATE AND SEVERE COVID-19 PATIENTS | Kidney Int Rep | 2022 | | CORD-19 |
| 6268 | Tozinameran: Vaccination failure: 10 case reports | N/A | 2022 | | CORD-19 |
| 6269 | Antineoplastics: COVID-19: case report | N/A | 2022 | | CORD-19 |
| 6270 | Azd-1222: Immune thrombocytopaenia: case report | N/A | 2022 | | CORD-19 |
| 6271 | Multiple drugs: Vaccine induced thrombotic thrombocytopenia, adrenal haematoma and lack of efficacy: case report | N/A | 2022 | | CORD-19 |
| 6272 | COVID-19-Vaccine-Pfizer-BioNTech: Anti-leucine rich glioma inactivated 1 autoimmune encephalitis: case report | N/A | 2022 | | CORD-19 |
| 6273 | AZD-1222: New-onset systemic lupus erythematosus with class V lupus nephritis: case report | N/A | 2022 | | CORD-19 |
| 6274 | Ciclosporin/prednisolone: COVID-19 infection and Klebsiella pneumoniae septicaemia: case report | N/A | 2022 | | CORD-19 |
| 6275 | Daptomycin: Acute eosinophilic pneumonitis: case report | N/A | 2022 | | CORD-19 |
| 6276 | COVID-19 Vaccine Pfizer BioNTech: Acute macular neuroretinopathy: case report | N/A | 2022 | | CORD-19 |
| 6277 | AZD-1222: Atypical Kawasaki's disease: case report | N/A | 2022 | | CORD-19 |
| 6278 | Rectifying ZnO-Na/ZnO-Al aerogels p-n homojunctions Semiconductor ZnO aerogels were synthesized by a sol–gel process with different concentrations (2.5–7.5 wt.%) of Al (n-type) or Na (p-type) and dried under supercritical CO(2). The materials were calcined at 500 °C to remove the organic content and to crystallize the ZnO. The microstructure of the ZnO-based aerogels comprises a porous structure with hexagonal and platelet-shaped interconnected particles. The bandgap of the aerogels doped with Al decreased significantly compared to pure, undoped ZnO aerogels, while their specific surface area increased. For the electrical characterization of the ZnO–Na/ZnO–Al junctions, the doped ZnO aerogels were deposited on commercial glass substrates coated with indium tin oxide (ITO) by drop casting method. The I-V curves of the p-n homojuntions revealed a characteristic diode rectifying behavior. | N/A | 2022 | | CORD-19 |
| 6279 | Enoxaparin sodium: Postoperative fever: case report | N/A | 2022 | | CORD-19 |
| 6280 | Tozinameran: Graves' disease and type 1 diabetes mellitus: case report | N/A | 2022 | | CORD-19 |
| 6281 | Tozinameran: Myocarditis: case report | N/A | 2022 | | CORD-19 |
| 6282 | Levofloxacin: DRESS syndrome: case report | N/A | 2022 | | CORD-19 |
| 6283 | AZD-1222: Immune thrombocytopenia and thrombosis: case report | N/A | 2022 | | CORD-19 |
| 6284 | Increase in thromboembolic ADRs from oral contraceptives during COVID-19 pandemic in Spain | N/A | 2022 | | CORD-19 |
| 6285 | Rituximab: Hypogammaglobulinaemia and recurrent COVID-19 infection: case report | N/A | 2022 | | CORD-19 |
| 6286 | Azd-1222: Vaccine induced thrombocytopenia and thrombosis: 2 case reports | N/A | 2022 | | CORD-19 |
| 6287 | Antineoplastics: Various toxicities: case report | N/A | 2022 | | CORD-19 |
| 6288 | Ad26.COV2-S: Multisystem inflammatory syndrome: case report | N/A | 2022 | | CORD-19 |
| 6289 | Tozinameran: Severe nonanaphylactic allergic reaction: case report | N/A | 2022 | | CORD-19 |
| 6290 | Methylprednisolone/mycophenolate-mofetil/tacrolimus: COVID-19 Infection: case report | N/A | 2022 | | CORD-19 |
| 6291 | Tozinameran: Skin reaction with rust-like discolouration: case report | N/A | 2022 | | CORD-19 |
| 6292 | Dexamethasone/tocilizumab/tofacitinib: Lack of efficacy following off label use: 2 case reports | N/A | 2022 | | CORD-19 |
| 6293 | Dexamethasone/methylprednisolone: Kaposi's sarcoma secondary to human herpes virus-8 reactivation: case report | N/A | 2022 | | CORD-19 |
| 6294 | Tozinameran: Nephrotic syndrome and minimal change disease: case report | N/A | 2022 | | CORD-19 |
| 6295 | Multiple drugs: Various toxicities: 14 case reports | N/A | 2022 | | CORD-19 |
| 6296 | AZD-1222: Immune thrombocytopenia: case report | N/A | 2022 | | CORD-19 |
| 6297 | Tozinameran: Immunoglobulin A-dominant leukocytoclastic vasculitis (Henoch-Schonlein purpura): case report | N/A | 2022 | | CORD-19 |
| 6298 | Coronavirus-vaccine: Syndrome of inappropriate anti-diuresis hormone: case report | N/A | 2022 | | CORD-19 |
| 6299 | Elasomeran: Eruptive pseudoangiomatosis: case report | N/A | 2022 | | CORD-19 |
| 6300 | Tozinameran: Acute myocarditis: case report | N/A | 2022 | | CORD-19 |
